Text Size

Quality of Life in Children With HIV Infection

This study is currently recruiting participants.
Verified May 2013 by University of Medicine and Dentistry New Jersey
Sponsor:
Collaborator:
National Institute of Nursing Research (NINR)
Information provided by (Responsible Party):
University of Medicine and Dentistry New Jersey
ClinicalTrials.gov Identifier:
NCT00075153
First received: January 2, 2004
Last updated: May 24, 2013
Last verified: May 2013
History of Changes
  Purpose

The purpose of this study is to characterize the quality of life (QOL) and longitudinal patterns of change in QOL outcomes in children and youth with HIV infection; to identify demographic, social, disease status, treatment, and health care utilization factors that predict longitudinal changes in outcomes; to develop a conceptual model that characterizes the effects of specific factors that predict longitudinal changes in QOL; and to characterize the influence of HIV symptoms on QOL outcomes in the domains of health perceptions, physical, psychological, and social role functioning.


Condition Intervention
HIV Infections
 Behavioral: Nursing Intervention

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Quality of Life in Children With HIV Infection

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Further study details as provided by University of Medicine and Dentistry New Jersey:

Estimated Enrollment: 1993
Study Start Date: September 2001
Estimated Study Completion Date: August 2004
Detailed Description:

This is a Phase III study. This study will use national data available through a prospective, observational, longitudinal study of children and youth (n=1,993) from birth to 25 with HIV infection (Pediatric AIDS Clinical Trials Group Protocol 219/219C) to develop knowledge about the quality of life (QOL) and the factors that affect it in order to be able to implement effective nursing interventions and clinical programs to support and improve QOL in this vulnerable population of children.

  Eligibility

Ages Eligible for Study:   10 Months to 25 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • Children and youth, from birth to 25 years old, who acquired HIV through birth.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00075153

Locations
United States, New Jersey
University of Medicine and Dentistry of NJ Recruiting
Newark, New Jersey, United States, 07103
Contact: Deborah S Storm, PhD     973-972-0400     STORMDS@UMDNJ.EDU    
Sponsors and Collaborators
University of Medicine and Dentistry New Jersey
National Institute of Nursing Research (NINR)
  More Information

No publications provided

Responsible Party: University of Medicine and Dentistry New Jersey
ClinicalTrials.gov Identifier: NCT00075153     History of Changes
Other Study ID Numbers: 1-R01-NR007975-01, R01NR007975
Study First Received: January 2, 2004
Last Updated: May 24, 2013
Health Authority: United States: Federal Government

Keywords provided by University of Medicine and Dentistry New Jersey:
ADOLESCENCE
HIV INFECTION
PEDIATRIC AIDS
QUALITY OF LIFE
HIV

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
 Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Slow Virus Diseases

ClinicalTrials.gov processed this record on June 18, 2013